Articles

Comparison of Ocular Characteristic Between Major Thalassemia and Healthy Group

Abstract

To determine and compare ocular characteristics and refractive errors between major thalassemia patients and normal subjects. In this study, 71 thalassemia major patients and 79 age and sex-matched healthy subjects that were selected in an ongoing manner underwent complete optometric and ophthalmic examinations, including autorefraction, subjective refraction, fluorescein tear break-up time, and pachymetry after anthropometric measurements. The results showed that the mean UCVA was better in the control group versus the thalassemia group (P<0.001), while there was no difference in BCVA between the two groups (P=0.416). Moreover, the mean spherical equivalent was 0.38±0.13 D less in the thalassemia group compared to the control group (P=0.007), while corneal power (P<0.001) and cylinder power (P=0.001) were larger in thalassemia patients. The most common type of astigmatism was against the rule pattern in thalassemia patients and with the rule pattern in the control group (P<0.001). The mean tear break-up time was 11.35±6.43 in the thalassemia group and 14.63±5.79 in the control group (P=0.001), and the mean near the point of accommodation (NPA) (P=0.009) and near the point of convergence (NPC). (P=0.003) were significantly smaller in the thalassemia group compared to the control group. These patients suffer from a myopic shift due to exaggerated responses to changes in ocular growth, dry eye secondary to goblet cell loss, and a higher prevalence of vertical astigmatism due to eyelid laxity and pressure on the cornea. Therefore, regular ophthalmological evaluations are highly recommended in these patients.

1. Heydarian S, Jafari R, Karami H. Refractive errors and ocular biometry components in thalassemia major patients. Int Ophthalmol 2016;36:267-71 .
2. Aksoy A, Aslankurt M, Aslan L, Gül O, Garipardıç M, Celik O, et al. Ocular findings in children with thalassemia major in Eastern Mediterranean. Int J Ophthalmol. 2014;7:118-21 .
3. Elkitkat RS, El-Shazly AA, Ebeid WM, Deghedy MR. Relation of anthropometric measurements to ocular biometric changes and refractive error in children with thalassemia. Eur J Ophthalmol 2018;28:139-43 .
4. Hashim ZA, Mutlag SS. Ophthalmologic Changes in Thalassemia Patients. Int J Pharm Sci Rev Res 2017;9:2237-9 .
5. Schrier SL. Pathophysiology of the thalassemias. The Albion Walter Hewlett Award presentation. West J Med 1997;167:82-9 .
6. Cao A, Galanello R. Beta-thalassemia. Genet Med 2010;12:61-76.
7. Voskaridou E, Terpos E. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br J Haematol 2004;127:127-39.
8. Weatherall DJ, Clegg JB. Historical perspectives. In: The Thalassemia syndromes. 4th ed. Oxford, UK: Blackwell Scientific, 2001 .
9. Fahim FM, Saad K, Askar EA, Eldin EN, Thabet AF. Growth Parameters and Vitamin D status in Children with Thalassemia Major in Upper Egypt. Int J Hematol Oncol Stem Cell Res 2013;7:10-4 .
10. Kundu A, Purban Ganguly D, Sinharay A, Patil P, Sharma K, Bandyopadhyay M. A Study to Assess the Ocular Biometric Parameters and Prevalence of Refractive Errors among Thalassemic Children in a Rural Based Tertiary Hospital. Int J Med Health Sci Res 2017;7:160-5 .
11. Nowroozzadeh MH, Kalantari Z, Namvar K, Meshkibaf MH. Ocular refractive and biometric characteristics in patients with thalassaemia major. Clin Exp Optom 2011;94:361-6 .
12. Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord 2003;3:4 .
13. Jafari R, Heydarian S, Karami H, Shektaei MM, Dailami KN, Amiri AA, et al. Ocular abnormalities in multi-transfused beta-thalassemia patients. Indian J Ophthalmol 2015;63:710-5 .
14. Kassab-Chekir A, Laradi S, Ferchichi S, Khelil AH, Feki M, Amri F, et al. Oxidant, antioxidant status and metabolic data in patients with beta-thalassemia. Clin Chim Acta 2003;338:79-86 .
15. Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America. Br J Haematol 2009;146:546-56 .
16. Gartaganis SP, Georgakopoulos CD, Exarchou A, Mela EK, Psachoulia C, Eliopoulou MI, et al. Alterations in conjunctival cytology and tear film dysfunction in patients with beta-thalassemia. Cornea 2003;22:591-7 .
17. Parentin F, Perissutti P. Congenital Growth Hormone Deficiency and Eye Refraction: A Longitudinal Study. Ophthalmologica 2005;219:226-31 .
18. Parentin F, Tonini G, Perissutti P. Refractive evaluation in children with growth defect. Curr Eye Res 2004;28:11-5 .
19. Abolghasemi H, Amid A, Zeinali S, Radfar MH, Eshghi P, Rahiminejad MS, et al. Thalassemia in Iran: epidemiology, prevention, and management. J Pediatr Hematol Oncol 2007;29:233-8 .
20. Khalaj M, Sarokhani MR, Mahyar A, Jahan Hashemi H, Godsi F. Assessing the Refractive Errors in Beta-Thalassemia Major Patients. Jour Guilan Uni Med Sci 2009;17:42-9 .
21. Ghazanfari A, Jafarzadehpour E, Heydarian S, Dailami KN, Karami H. Comparison of contrast sensitivity in β-thalassemia patients treated by deferoxamine or deferasirox. J Optom 2019;12:168-73 .
22. Hashemi H, Khabazkhoob M, Pakzad R, Yekta A, Heravian J, Nabovati P, et al. The prevalence of color vision deficiency in the northeast of Iran. J Curr Ophthalmol 2019;31:80-5 .
23. Liaska A, Petrou P, Georgakopoulos CD, Diamanti R, Papaconstantinou D, Kanakis MG, et al. β-Thalassemia and ocular implications: a systematic review. BMCOphthalmol 2016;16:102 .
24. Repanti M, Gartaganis SP, Nikolakopoulou NM, Ellina A, Papanastasiou DA. Study of the eye and lacrimal glands in experimental iron overload in rats in vivo. Anat Sci Int 2008;83:11-6.
25. Hashemi H, Pakzad R, Yekta A, Asharlous A, Aghamirsalim M, Ostadimoghaddam H, et al. The distribution of near point of convergence in an Iranian rural population: A population-based cross-sectional study. Saudi J Ophthalmol 2019;33:148-52.
Files
IssueVol 59, No 10 (2021) QRcode
SectionArticles
DOI https://doi.org/10.18502/acta.v59i10.7767
Keywords
Beta-thalassemia Ocular Characteristic refractive errors Cohort study
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Koochakzadeh L, Hashemi H, Pakzad R, Hemmatian Rabbani Z, Heydarian S, Yekta A, Khoshhal F, Ostadimoghaddam H, Tajzadeh P, Sardari S, Khabazkhoob M. Comparison of Ocular Characteristic Between Major Thalassemia and Healthy Group. Acta Med Iran. 2021;59(10):603-609.